First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Stock Price Down 0.4% – Should You Sell?

Posted by ABMN Staff on Jun 17th, 2026

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Free Report)’s stock price was down 0.4% on Tuesday . The company traded as low as $35.50 and last traded at $35.67. Approximately 9,960 shares traded hands during trading, an increase of 27% from the average daily volume of 7,832 shares. The stock had previously closed at $35.81.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

The stock’s 50-day moving average is $34.51 and its two-hundred day moving average is $34.05. The stock has a market cap of $32.10 million, a P/E ratio of 14.51 and a beta of 0.47.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Thursday, March 26th were given a dividend of $0.0573 per share. The ex-dividend date was Thursday, March 26th. This represents a $0.23 annualized dividend and a yield of 0.6%.

Hedge Funds Weigh In On First Trust Nasdaq Pharmaceuticals ETF

Institutional investors have recently bought and sold shares of the business. NBC Securities Inc. lifted its position in First Trust Nasdaq Pharmaceuticals ETF by 33.0% during the fourth quarter. NBC Securities Inc. now owns 1,325 shares of the company’s stock valued at $44,000 after purchasing an additional 329 shares during the last quarter. Raymond James Financial Inc. bought a new position in First Trust Nasdaq Pharmaceuticals ETF during the second quarter valued at $57,000. Kestra Advisory Services LLC bought a new position in First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter valued at $59,000. Flagship Harbor Advisors LLC bought a new position in First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter valued at $205,000. Finally, Flputnam Investment Management Co. bought a new position in First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter valued at $230,000.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

(Get Free Report)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.